On optimal subset designs for phase II clinical trials with both total response and disease control (Q2242847)

From MaRDI portal
scientific article
Language Label Description Also known as
English
On optimal subset designs for phase II clinical trials with both total response and disease control
scientific article

    Statements

    On optimal subset designs for phase II clinical trials with both total response and disease control (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    10 November 2021
    0 references
    least expected total sample size
    0 references
    maximum type I error rate
    0 references
    minimum power
    0 references
    multinomial distribution
    0 references

    Identifiers